Article

Left atrial maximum volume is a recurrence predictor in lone-atrial fibrillation - An acoustic quantification study

Trakya University, Adrianoupolis, Edirne, Turkey
Japanese Heart Journal (Impact Factor: 0.4). 05/2002; 43(3):241-8. DOI: 10.1536/jhj.43.241
Source: PubMed

ABSTRACT Predictors of recurrence in lone atrial fibrillation have not been clearly identified. Acoustic quantification (AQ) is a promising method in the assessment of left atrial (LA) volumes. The purpose of the present study was to investigate the potential of LA volumes obtained by standard manual tracing and AQ methods in predicting AF-recurrence after restoring the sinus rhythm in patients with lone AF, and to test the agreement between the two approaches. Standard echocardiography combined with AQ was performed in 28 patients with lone AF one hour after the sinus rhythm was regained, and in 10 controls. LA volumes were determined by conventional manual tracing and AQ methods. AQ waveforms of LA were obtained by drawing a region of interest around the LA border. The agreement of the two methods was tested by Bland-Altman analysis. Patients were followed up for 6 months for the occurrence of AF recurrence. A good correlation was observed between AQ and manual tracing methods in determining both minimal (r=0.59) and maximal (r=0.88) LA volumes. Patients with AF recurrence had a significantly larger maximum LA volume as assessed with both methods (P<0.05 for both). M-mode derived LA dimension and isovolumic relaxation time were additional predictors of recurrence in patients with lone AF. In lone AF, patients prone to recurrence could be predicted by determining LA maximum volume assessed either by AQ or manual tracing methods. AQ provides on-line, accurate estimation of LA volumes.

0 Followers
 · 
70 Views
  • Source
    • "However the lack of evidence of benefit of rhythm control in the current literature may be explained by the limitations of antiarrhythmic drug therapy such as limited efficacy (many patients have AF recurrences), occurrence of proarrhythmogenic side effects and substantial drug–drug interactions. Left atrial (LA) size has previously been shown to be predictive of atrial fibrillation (AF) recurrence [3] [4] [5]. Left ventricular hypertrophy (LVH) leads to diastolic dysfunction, which in turn causes elevation of cardiac filling pressures and consequent atrial enlargement [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Atrial fibrillation (AF) patients with left ventricular hypertrophy (LVH) and diastolic dysfunction may derive benefit from being in sinus rhythm but no data are available to support this strategy in them. We sought to investigate effect of left ventricular remodeling on cardiovascular outcomes in AF patients undergoing rhythm control strategy. Methods We identified 1088 patients with echocardiographic data on left ventricular mass (LVM) enrolled in the AFFIRM trial. Using the American Society of Echocardiography (ASE) criteria, patients were divided into 4 categories: 1) normal geometry, 2) concentric remodeling, 3) eccentric hypertrophy, and 4) concentric hypertrophy. The primary endpoint was AF recurrence and the secondary endpoint was cardiovascular hospitalization (CVH). Results In rhythm control arm, median time to recurrence in patients with concentric LVH was 13.3 months (95% CI 8.2–24.5) vs. 28.3 months (95% CI 20.2–48.6) in patients without LVH. Concentric left ventricular hypertrophy (LVH) was independently predictive of AF recurrence (HR 1.49, 95% CI 1.10–2.01, p = 0.01) in rhythm control arm, but not in overall population or rate control arm. Both concentric and eccentric LVH were independently predictive of cardiovascular hospitalization (CVH) in the overall population, with respective HRs of 1.36 (1.04–1.78, p = 0.03) and 1.38 (1.02–1.85, p = 0.04). Conclusion Concentric LVH is predictive of AF recurrences when a predominantly pharmacologic rhythm-control strategy is employed. Different patterns of LVH seem to be important determinants of outcomes (AF recurrence and CVH). These findings may have important clinical implications for the management of patients with AF and LVH. Further studies are warranted to confirm our findings.
  • Source
    • "However the lack of evidence of benefit of rhythm control in the current literature may be explained by the limitations of antiarrhythmic drug therapy such as limited efficacy (many patients have AF recurrences), occurrence of proarrhythmogenic side effects and substantial drug–drug interactions. Left atrial (LA) size has previously been shown to be predictive of atrial fibrillation (AF) recurrence [3] [4] [5]. Left ventricular hypertrophy (LVH) leads to diastolic dysfunction, which in turn causes elevation of cardiac filling pressures and consequent atrial enlargement [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Atrial fibrillation (AF) patients with left ventricular hypertrophy (LVH) and diastolic dysfunction may derive benefit from being in sinus rhythm but no data are available to support this strategy in them. We sought to investigate effect of left ventricular remodeling on cardiovascular outcomes in AF patients undergoing rhythm control strategy. We identified 1088 patients with echocardiographic data on left ventricular mass (LVM) enrolled in the AFFIRM trial. Using the American Society of Echocardiography (ASE) criteria, patients were divided into 4 categories: 1) normal geometry, 2) concentric remodeling, 3) eccentric hypertrophy, and 4) concentric hypertrophy. The primary endpoint was AF recurrence and the secondary endpoint was cardiovascular hospitalization (CVH). In rhythm control arm, median time to recurrence in patients with concentric LVH was 13.3months (95% CI 8.2-24.5) vs. 28.3months (95% CI 20.2-48.6) in patients without LVH. Concentric left ventricular hypertrophy (LVH) was independently predictive of AF recurrence (HR 1.49, 95% CI 1.10-2.01, p=0.01) in rhythm control arm, but not in overall population or rate control arm. Both concentric and eccentric LVH were independently predictive of cardiovascular hospitalization (CVH) in the overall population, with respective HRs of 1.36 (1.04-1.78, p=0.03) and 1.38 (1.02-1.85, p=0.04). Concentric LVH is predictive of AF recurrences when a predominantly pharmacologic rhythm-control strategy is employed. Different patterns of LVH seem to be important determinants of outcomes (AF recurrence and CVH). These findings may have important clinical implications for the management of patients with AF and LVH. Further studies are warranted to confirm our findings.
    International journal of cardiology 04/2014; 174(2). DOI:10.1016/j.ijcard.2014.04.011 · 6.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In information visualization, as the volume and complexity of the data increases, researchers require more powerful visualization tools that enable them to more effectively explore multidimensional datasets. We discuss the general utility of a novel visualization spreadsheet framework. Just as a numerical spreadsheet enables exploration of numbers, a visualization spreadsheet enables exploration of visual forms of information. We show that the spreadsheet approach facilitates certain information visualization tasks that are more difficult using other approaches. Unlike traditional spreadsheets, which store only simple data elements and formulas in each cell, a visualization spreadsheet cell can hold an entire complex data set, selection criteria, viewing specifications, and other information needed for a full-fledged information visualization. Similarly, inter-cell operations are far more complex, stretching beyond simple arithmetic and string operations to encompass a range of domain-specific operators. We have built two prototype systems that illustrate some of these research issues. The underlying approach in our work allows domain experts to define new data types and data operations, and enables visualization experts to incorporate new visualizations, viewing parameters, and view operations.
    Information Visualization, 1997. Proceedings., IEEE Symposium on; 11/1997
Show more